Ocuphire Pharma Results Presentation Deck

CO 6 Ocuphire PHARMA Topline MIRA-2 Phase 3 Results Randomized, Parallel Arm, Double-Masked, Placebo- Controlled Study of the Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Healthy Subjects

View entire presentation